Literature DB >> 33738697

Correction to: Sequential Treatment of Sorafenib-Regorafenib Versus Sorafenib-Physician's Choice: A Propensity Score-Matched Analysis.

Yeonghak Bang1, Changhoon Yoo1, Mario Scartozzi2, Sara Lonardi3,4, Hyung-Don Kim1, Caterina Vivaldi5, Margherita Rimini6, Giovanni Luca Frassineti7, Sook Ryun Park1, Mario Domenico Rizzato4, Min-Hee Ryu1, Francesca Salani5, Ilario Giovanni Rapposelli7, Baek-Yeol Ryoo1, Vittorina Zagonel4, Valentina Massa5, Martina Valgiusti7, Valentina Burgio8, Stefano Cascinu8,9, Andrea Casadei-Gardini10,11.   

Abstract

Entities:  

Year:  2021        PMID： 33738697     DOI： 10.1007/s11523-021-00808-3

Source DB:  PubMed          Journal:  Target Oncol        ISSN： 1776-2596            Impact factor:   4.493


× No keyword cloud information.
  1 in total

1.  Deterioration of liver function and aging disturb sequential systemic therapy for unresectable hepatocellular carcinoma.

Authors:  Shigeo Shimose; Atsushi Hiraoka; Masatoshi Tanaka; Hideki Iwamoto; Takaaki Tanaka; Kazunori Noguchi; Hajime Aino; Taizo Yamaguchi; Satoshi Itano; Hideya Suga; Takashi Niizeki; Etsuko Moriyama; Tomotake Shirono; Yu Noda; Naoki Kamachi; Shusuke Okamura; Masahito Nakano; Takumi Kawaguchi; Ryoko Kuromatsu; Hironori Koga; Takuji Torimura
Journal:  Sci Rep       Date:  2022-10-11       Impact factor: 4.996
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.